Proposed Data Collection Submitted for Public Comment and Recommendations, 5237-5239 [2024-01550]
Download as PDF
5237
Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices
Proposed Project
Preventive Health and Health Services
Block Grant (OMB Control No. 0920–
0106, Exp. 2/29/2024)—Revision—
National Center for State, Tribal, Local
and Territorial Public Health
Infrastructure and Workforce
(NCSTLTPHIW), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The CDC’s National Center for State,
Tribal, Local and Territorial Public
Health Infrastructure and Workforce
(NCSTLTPHIW) plays a vital role in
helping health agencies work to
enhance their capacity and improve
their performance to strengthen the
public health system on all levels.
NCSTLTPHIW is CDC’s primary
connection to health officials and
leaders of State, Tribal, local, and
Territorial public health agencies, as
well as other government leaders who
work with health departments.
NCSTLTPHIW administers the
Preventive Health and Health Services
Block Grant (PHHSBG) for health
promotion and disease prevention
programs. Sixty-one (61) recipients (50
states, the District of Columbia, two
American Indian Tribes, five U.S.
territories, and three freely associated
states) receive block grant funds to
address locally-defined public health
needs in innovative ways. The PHHSBG
allows awardees to prioritize the use of
funds to fill funding gaps in programs
that deal with leading causes of death
and disability, as well as the ability to
respond rapidly to emerging health
issues, including outbreaks of foodborne infections and water-borne
diseases.
As specified in the authorizing
legislation for the PHHSBG, CDC
collects information from recipients to
monitor their objectives and activities.
Since 2021, this information has been
reported through a web-based electronic
system, the Block Grant Information
System (BGIS). Each recipient is
required to submit a work plan with its
selected health outcome objectives, as
well as descriptions of the health
problems, identified target populations
(including portions of those populations
disproportionately affected by the
health problems), and activities to be
addressed in the planned work.
In this Revision, CDC requests OMB
approval to subdivide the previously
approved annual Workplan (12 hours)
into two sections: the ‘‘Workplan Start
and Advisory Committee Questions
Worksheet’’ (two hours) and the
‘‘Workplan Program Questions
Worksheet’’ (10 hours). There are no
changes to the previously approved
questions or the net annualized burden
estimate for the Workplan (732 hours).
However, questions have been
regrouped to improve logical flow, and
selected instructions to respondents
have been revised for clarity and ease of
use. The Annual Progress Report will be
continued without changes in total
burden hours (671 annualized burden
hours), though the burden table is
revised to describe how program
collects two different sets of questions
within the Annual Progress Report
(Interim progress questions (seven
hours) and Final progress questions
(four hours). These revisions to the
burden table enable program to better
monitor and provide technical
assistance to respondents. The Recipient
Information Collection will be deleted
from the burden table (¥122 annualized
burden hours). The BGIS will retain this
information, however, the one-time
burden of entering the Recipient
Information was accounted for in the
previous approval period.
CDC will continue to use the PHHSBG
information collection to identify
activities and personnel supported with
Block Grant funding, monitor
expenditure of funds and recipients’
progress toward their objectives,
conduct compliance reviews of Block
Grant recipients, and promote the use of
evidence-based guidelines and
interventions. OMB approval is
requested for three years. All
information is submitted annually
through the electronic BGIS. The total
annualized estimated burden is 1,403
hours. There are no costs to respondents
other than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
PHHS Block Grant Coordinator ......................
Workplan start and advisory committee
questions worksheet.
Workplan program questions worksheet .......
Annual Progress Report template (subset of
Interim Progress questions).
Annual Progress Report template (subset of
Final Progress questions).
PHHS Block Grant Coordinator ......................
PHHS Block Grant Coordinator ......................
PHHS Block Grant Coordinator ......................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[FR Doc. 2024–01549 Filed 1–25–24; 8:45 am]
[60Day–24–24CB; Docket No. CDC–2024–
0004]
lotter on DSK11XQN23PROD with NOTICES1
BILLING CODE 4163–18–P
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
VerDate Sep<11>2014
18:02 Jan 25, 2024
Jkt 262001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
ACTION:
Number of
responses per
respondent
Average
burden per
response
(in hours)
61
1
2
61
61
1
1
10
7
61
1
4
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Evaluation of an
Online Prostate Cancer Decision Aid.
This three-arm, randomized controlled
SUMMARY:
E:\FR\FM\26JAN1.SGM
26JAN1
5238
Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
trial (RCT) includes eight forms of data
collection including surveys and
interviews and will evaluate the impact
of a virtual human decision aid to help
improve the quality of prostate cancer
screening and treatment decisions.
DATES: CDC must receive written
comments on or before March 26, 2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0004 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
VerDate Sep<11>2014
18:02 Jan 25, 2024
Jkt 262001
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of an Online Prostate
Cancer Decision Aid—New—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Division of Cancer
Prevention and Control (DCPC) is
requesting a new, three-year OMB
approval to conduct a three-arm,
randomized controlled trial (RCT) to
evaluate the impact of a virtual human
decision aid to help improve the quality
of prostate cancer screening and
treatment decisions.
Talk to Nathan About Prostate Cancer
Screening (hereafter referred to as
Nathan) is DCPC’s online, interactive,
human simulation decision aid
designed to help men learn and make
informed decisions about prostate
cancer screening. A small, preliminary
evaluation of Nathan showed promise in
increasing men’s knowledge about
prostate cancer and likelihood of
engaging in shared decision-making
about prostate cancer screening with
their health care providers. At this time,
a larger, more systematic evaluation can
help to understand whether Nathan is
effective in areas such as improving
knowledge, overcoming health literacy
barriers, and resolving decisional
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
conflict, especially among priority
populations who are most likely to be
affected by prostate cancer and least
likely to be screened. Further, as some
experts consider the digital divide to be
the newest social determinant of health,
it is important to explore how, where,
and for which populations there may be
disparities in accessing and using
Nathan.
Broadly, the purpose of this
information collection is to: (1) assess
whether Nathan is more effective at
helping men make decisions about
prostate cancer screening than an
established decision aid or standard
educational materials; (2) determine if
changes or improvements to Nathan are
warranted; and (3) identify ways to
incorporate Nathan into primary care.
We will select four primary care clinics
to participate in this study. The RCT
includes a three-group parallel design
with one treatment arm and two control
arms to test the effectiveness of Nathan
for men aged 55–69. We will recruit 900
men aged 55–69 who have an upcoming
general health exam at one of the four
primary care clinics and randomize
them to one of three arms: (1) Nathan
(Intervention = 300 men); (2) the
Massachusetts Department of Public
Health’s (MDPH’s) Patient Decision Aid,
Get the Latest Facts about Screening for
Prostate Cancer (Control 1 = 300 men);
and (3) standard educational materials
from the National Cancer Institute (NCI),
Prostate Cancer Screening (PDQ®)—
Patient Version (Control 2 = 300 men).
Eight information collection forms
will be implemented to answer our
evaluation questions. These include a
provider survey; a patient eligibility
screener; patient pre-exposure, postexposure, and post-clinic visit surveys;
a patient usability survey; patient user
experience interviews; and clinic
coordinator interviews. Each instrument
will be administered once per
respondent throughout the course of the
study. The provider survey and clinic
coordinator interviews will be
conducted in English only. All other
information collections will be
conducted in English or Spanish. The
total response burden is estimated to be
1,129 hours. There are no costs to
respondents other than their time to
participate in data collection activities.
E:\FR\FM\26JAN1.SGM
26JAN1
5239
Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Primary care providers ......................
Men ages 55–69 ...............................
Men ages 55–69 ...............................
Men ages 55–69 ...............................
Men ages 55–69 ...............................
Men ages 55–69 ...............................
Men ages 55–69 ...............................
Clinic coordinators ............................
Provider survey ................................
Patient eligibility screener ................
Pre-exposure survey ........................
Post-exposure survey ......................
Post-clinic survey .............................
Usability survey ................................
User experience interview ................
Clinic coordinator interview ..............
40
900
900
900
300
30
900
4
1
1
1
1
1
1
1
1
10/60
8/60
20/60
20/60
18/60
20/60
20/60
30/60
7
120
300
300
90
10
300
2
Total ...........................................
...........................................................
........................
........................
........................
1,129
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–01550 Filed 1–25–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10887]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
VerDate Sep<11>2014
18:02 Jan 25, 2024
Jkt 262001
Comments must be received by
March 26, 2024.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address:
CMS, Office of Strategic Operations and
Regulatory Affairs, Division of
Regulations Development, Attention:
Document Identifier/OMB Control
Number: lll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
DATES:
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10887 The Medicare
Advantage and Prescription Drug
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Programs: Part C and Part D Medicare
Advantage Prescription Drug (MARx)
System Updates for the Medicare
Prescription Payment Plan Program
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: The Medicare
Advantage and Prescription Drug
Programs: Part C and Part D Medicare
Advantage Prescription Drug (MARx)
System Updates for the Medicare
Prescription Payment Plan Program;
Use: The IRA amended the Act by
adding section 1860D–2(b)(2)(E) which,
beginning January 1, 2025, establishes
the Medicare Prescription Payment Plan
program (hereinafter referred to as the
‘‘program’’). Under this program, MA
Organizations offering Part D coverage
and Part D sponsors (collectively ‘‘Part
D plans’’ or ‘‘Plans’’) are required to
offer enrollees the option to pay their
Part D cost sharing in monthly amounts
spread out over the plan year based on
the formulae described in section
1860D–2(b)(2)(E)(iv) of the Act.
E:\FR\FM\26JAN1.SGM
26JAN1
Agencies
[Federal Register Volume 89, Number 18 (Friday, January 26, 2024)]
[Notices]
[Pages 5237-5239]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01550]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-24CB; Docket No. CDC-2024-0004]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Evaluation of an Online Prostate Cancer Decision Aid. This
three-arm, randomized controlled
[[Page 5238]]
trial (RCT) includes eight forms of data collection including surveys
and interviews and will evaluate the impact of a virtual human decision
aid to help improve the quality of prostate cancer screening and
treatment decisions.
DATES: CDC must receive written comments on or before March 26, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0004 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of an Online Prostate Cancer Decision Aid--New--National
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC), Division of
Cancer Prevention and Control (DCPC) is requesting a new, three-year
OMB approval to conduct a three-arm, randomized controlled trial (RCT)
to evaluate the impact of a virtual human decision aid to help improve
the quality of prostate cancer screening and treatment decisions.
Talk to Nathan About Prostate Cancer Screening (hereafter referred
to as Nathan) is DCPC's online, interactive, human simulation decision
aid designed to help men learn and make informed decisions about
prostate cancer screening. A small, preliminary evaluation of Nathan
showed promise in increasing men's knowledge about prostate cancer and
likelihood of engaging in shared decision-making about prostate cancer
screening with their health care providers. At this time, a larger,
more systematic evaluation can help to understand whether Nathan is
effective in areas such as improving knowledge, overcoming health
literacy barriers, and resolving decisional conflict, especially among
priority populations who are most likely to be affected by prostate
cancer and least likely to be screened. Further, as some experts
consider the digital divide to be the newest social determinant of
health, it is important to explore how, where, and for which
populations there may be disparities in accessing and using Nathan.
Broadly, the purpose of this information collection is to: (1)
assess whether Nathan is more effective at helping men make decisions
about prostate cancer screening than an established decision aid or
standard educational materials; (2) determine if changes or
improvements to Nathan are warranted; and (3) identify ways to
incorporate Nathan into primary care. We will select four primary care
clinics to participate in this study. The RCT includes a three-group
parallel design with one treatment arm and two control arms to test the
effectiveness of Nathan for men aged 55-69. We will recruit 900 men
aged 55-69 who have an upcoming general health exam at one of the four
primary care clinics and randomize them to one of three arms: (1)
Nathan (Intervention = 300 men); (2) the Massachusetts Department of
Public Health's (MDPH's) Patient Decision Aid, Get the Latest Facts
about Screening for Prostate Cancer (Control 1 = 300 men); and (3)
standard educational materials from the National Cancer Institute
(NCI), Prostate Cancer Screening (PDQ[supreg])--Patient Version
(Control 2 = 300 men).
Eight information collection forms will be implemented to answer
our evaluation questions. These include a provider survey; a patient
eligibility screener; patient pre-exposure, post-exposure, and post-
clinic visit surveys; a patient usability survey; patient user
experience interviews; and clinic coordinator interviews. Each
instrument will be administered once per respondent throughout the
course of the study. The provider survey and clinic coordinator
interviews will be conducted in English only. All other information
collections will be conducted in English or Spanish. The total response
burden is estimated to be 1,129 hours. There are no costs to
respondents other than their time to participate in data collection
activities.
[[Page 5239]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Primary care providers........ Provider survey. 40 1 10/60 7
Men ages 55-69................ Patient 900 1 8/60 120
eligibility
screener.
Men ages 55-69................ Pre-exposure 900 1 20/60 300
survey.
Men ages 55-69................ Post-exposure 900 1 20/60 300
survey.
Men ages 55-69................ Post-clinic 300 1 18/60 90
survey.
Men ages 55-69................ Usability survey 30 1 20/60 10
Men ages 55-69................ User experience 900 1 20/60 300
interview.
Clinic coordinators........... Clinic 4 1 30/60 2
coordinator
interview.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,129
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-01550 Filed 1-25-24; 8:45 am]
BILLING CODE 4163-18-P